Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,600
Closed -$100K 1037
2026
Q1
$100K Sell
1,600
-1
-0.1% -$70 0.06% 158
2025
Q4
$106K Sell
1,601
-2,726
-63% -$176K 0.06% 150
2025
Q3
$291K Buy
4,327
+2,621
+154% +$207K 0.16% 98
2025
Q2
$149K Buy
1,706
+48
+3% +$3.76K 0.09% 122
2025
Q1
$113K Buy
1,658
+24
+1% +$1.96K 0.08% 125
2024
Q4
$127K Sell
1,634
-13
-0.8% -$962 0.08% 129
2024
Q3
$110K Buy
1,647
+1
+0.1% +$82 0.08% 133
2024
Q2
$187K Hold
1,646
0.15% 90
2024
Q1
$228K Hold
1,646
0.2% 81
2023
Q4
$204K Buy
1,646
+16
+1% +$1.64K 0.19% 81
2023
Q3
$152K Sell
1,630
-4
-0.2% -$451 0.12% 109
2023
Q2
$210K Hold
1,634
0.16% 89
2023
Q1
$190K Buy
1,634
+30
+2% +$3.36K 0.15% 96
2022
Q4
$182K Sell
1,604
-112
-7% -$12.3K 0.16% 98
2022
Q3
$138K Hold
1,716
0.11% 140
2022
Q2
$128K Buy
1,716
+4
+0.2% +$365 0.09% 150
2022
Q1
$219K Buy
1,712
+36
+2% +$3.94K 0.15% 117
2021
Q4
$225K Sell
1,676
-20
-1% -$2.87K 0.15% 122
2021
Q3
$232K Sell
1,696
-24
-1% -$3.03K 0.16% 114
2021
Q2
$184K Buy
1,720
+120
+8% +$11.5K 0.13% 130
2021
Q1
$144K Sell
1,600
-1,200
-43% -$113K 0.11% 150
2020
Q4
$259K Buy
+2,800
New +$250K 0.22% 96

Other funds holding DXCM

Wolff Wiese Magana's DXCM Position: Q2 2026 in Review

Wolff Wiese Magana sold out of DexCom (DXCM) in Q2 2026, closing a stake of 1,600 shares — an estimated $100K sold.

Wolff Wiese Magana first reported a position in DXCM in Q4 2020 and held it in 22 quarters. The position peaked at $291K in Q3 2025. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Wolff Wiese Magana reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Wolff Wiese Magana sold 1,600 DexCom shares in Q2 2026, an estimated $100K.
  • Wolff Wiese Magana first reported a position in DexCom in Q4 2020 and held it in 22 quarters.
  • Wolff Wiese Magana's DexCom position peaked at $291K in Q3 2025.
  • 224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.